论文部分内容阅读
自发现人乳头状瘤病毒(HPV)是浸润性宫颈癌的病因之后,研究人员进一步开发了HPV DNA检查用于该病的筛查。2009年,印度学者在《新英格兰医学杂志》上发表的研究表明,与传统宫颈巴氏涂片细胞学检查或宫颈醋酸染色肉眼观察相比,HPV筛查能更显著降低晚期宫颈癌的发生率和死亡率。2012年,美国预防工作组在《内科学年鉴》上发文指出,当对30~65岁女性行宫颈癌筛查时,应联用HPV检查与宫颈细胞学检查。那么,二者的筛查效果孰优孰劣?2013
Since the discovery of human papillomavirus (HPV) is the etiology of invasive cervical cancer, the researchers further developed HPV DNA tests for the screening of the disease. In 2009, a study published by Indian scholars in the New England Journal of Medicine showed that HPV screening can significantly reduce the incidence of advanced cervical cancer compared with the conventional cervical pap smear cytology or cervical acetic acid staining And mortality. In 2012, the United States Preventive Working Group issued a statement in the Annals of Internal Medicine stating that HPV screening and cervical cytology should be used when screening cervical cancer in women aged 30 to 65 years. Well, the two screening effect is better? 2013